Humira, also known as adalimunab, is an injected treatment used to treat mild to moderate psoriasis (an autoimmune skin condition). According to the National Psoriasis Foundation, it was approved for use in psoriasis patients in 2008.
Features
Humira decreases the body's amount of a substance called tumor necrosis factor alpha, which is responsible for inflammation, according to Drug Information Online.
Dosage
The National Psoriasis Foundation states that Humira is given as a subcutaneous (underneath the skin) injection. The first dose of Humira is 80 milligrams and then on day 8, you will inject 40 milligrams of Humira every other week.
Side Effects
Common side effects include headache, stomach pain, nausea and bleeding at the injection site. Call your doctor if you experience these symptoms.
Warning
Do not use Humira if you have any active or recurring infections, according to the National Psoriasis Foundation. Tell your doctor about your prior medical history, allergies and medications you are taking.
Overdose
Seek immediate help if you overdose on Humira. According to Drug Information Online, an overdose should not be life-threatening.
